RS62113B1 - Farmaceutske kompozicije antagoniste 5-ht6 - Google Patents

Farmaceutske kompozicije antagoniste 5-ht6

Info

Publication number
RS62113B1
RS62113B1 RS20210868A RSP20210868A RS62113B1 RS 62113 B1 RS62113 B1 RS 62113B1 RS 20210868 A RS20210868 A RS 20210868A RS P20210868 A RSP20210868 A RS P20210868A RS 62113 B1 RS62113 B1 RS 62113B1
Authority
RS
Serbia
Prior art keywords
methyl
bromophenyl
piperazinyl
sulfonyl
methoxy
Prior art date
Application number
RS20210868A
Other languages
English (en)
Serbian (sr)
Inventor
Ramakrishna Nirogi
Koteshwara Mudigonda
Dhanunjay Kumar Dogiparti
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Publication of RS62113B1 publication Critical patent/RS62113B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RS20210868A 2016-10-03 2017-09-29 Farmaceutske kompozicije antagoniste 5-ht6 RS62113B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201641033741 2016-10-03
EP17794060.8A EP3518905B1 (fr) 2016-10-03 2017-09-29 Compositions pharmaceutiques d'antagoniste de 5-ht6
PCT/IB2017/056009 WO2018065869A1 (fr) 2016-10-03 2017-09-29 Compositions pharmaceutiques d'antagoniste de 5-ht6

Publications (1)

Publication Number Publication Date
RS62113B1 true RS62113B1 (sr) 2021-08-31

Family

ID=60245136

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20210868A RS62113B1 (sr) 2016-10-03 2017-09-29 Farmaceutske kompozicije antagoniste 5-ht6

Country Status (25)

Country Link
US (1) US20190336497A1 (fr)
EP (1) EP3518905B1 (fr)
JP (1) JP6669937B2 (fr)
KR (1) KR102083135B1 (fr)
CN (1) CN109789098A (fr)
AU (1) AU2017339755B2 (fr)
CA (1) CA3038620C (fr)
CY (1) CY1124539T1 (fr)
DK (1) DK3518905T3 (fr)
EA (1) EA036235B1 (fr)
ES (1) ES2879675T3 (fr)
HR (1) HRP20211092T1 (fr)
HU (1) HUE055452T2 (fr)
IL (1) IL265662B (fr)
LT (1) LT3518905T (fr)
MA (1) MA46358B1 (fr)
MD (1) MD3518905T2 (fr)
MX (1) MX386462B (fr)
PL (1) PL3518905T3 (fr)
PT (1) PT3518905T (fr)
RS (1) RS62113B1 (fr)
SI (1) SI3518905T1 (fr)
SM (1) SMT202100403T1 (fr)
WO (1) WO2018065869A1 (fr)
ZA (1) ZA201901734B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110799189A (zh) * 2017-07-03 2020-02-14 苏文生命科学有限公司 纯5-ht6受体拮抗剂的新用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4559230B2 (ja) * 2002-11-28 2010-10-06 スベン ライフ サイエンシズ リミティド セロトニン受容体に対する親和性を有する新規ｎ−アリールスルホニル−３−置換されたインドール、その調製方法、それを含有する医薬組成物
EA009367B1 (ru) * 2002-12-18 2007-12-28 Сувен Лайф Сайенсиз Лимитед ПРОИЗВОДНЫЕ 5-ТИА-5-ДИОКСО-4b-АЗАИНДЕНО[2,1-a]ИНДЕНА, ОБЛАДАЮЩИЕ АФФИННОСТЬЮ К РЕЦЕПТОРУ СЕРОТОНИНА
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
HUE036008T2 (hu) * 2013-12-02 2018-06-28 Suven Life Sciences Ltd Eljárás 1-[(2-brómfenil)szulfonil]-5-metoxi-3-[(4-metil-1-piperazinil)metil]-1H-indol-dimezilát-monohidrát nagyüzemi léptékben történõ elõállítására

Also Published As

Publication number Publication date
WO2018065869A1 (fr) 2018-04-12
MX386462B (es) 2025-03-19
LT3518905T (lt) 2021-08-10
US20190336497A1 (en) 2019-11-07
JP6669937B2 (ja) 2020-03-18
MA46358B1 (fr) 2021-08-31
IL265662A (en) 2019-05-30
HRP20211092T1 (hr) 2021-10-15
JP2019529471A (ja) 2019-10-17
MD3518905T2 (ro) 2021-09-30
AU2017339755B2 (en) 2019-11-07
PL3518905T3 (pl) 2021-10-25
KR102083135B1 (ko) 2020-02-28
ES2879675T3 (es) 2021-11-22
SI3518905T1 (sl) 2021-11-30
SMT202100403T1 (it) 2021-09-14
IL265662B (en) 2019-11-28
KR20190050858A (ko) 2019-05-13
EP3518905A1 (fr) 2019-08-07
HUE055452T2 (hu) 2021-11-29
CY1124539T1 (el) 2022-07-22
MX2019003815A (es) 2019-08-12
PT3518905T (pt) 2021-07-14
DK3518905T3 (da) 2021-07-19
CA3038620C (fr) 2020-05-26
EA036235B1 (ru) 2020-10-16
EA201990827A1 (ru) 2019-07-31
AU2017339755A1 (en) 2019-04-18
CA3038620A1 (fr) 2018-04-12
BR112019006588A2 (pt) 2019-07-02
NZ752060A (en) 2020-09-25
ZA201901734B (en) 2020-11-25
CN109789098A (zh) 2019-05-21
EP3518905B1 (fr) 2021-04-28

Similar Documents

Publication Publication Date Title
US12251375B2 (en) Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonate
RU2716025C1 (ru) ЛЕКАРСТВЕННАЯ ФОРМА С УЛУЧШЕННЫМИ ХАРАКТЕРИСТИКАМИ pH-ЗАВИСИМОГО ВЫСВОБОЖДЕНИЯ ПРЕПАРАТА, СОДЕРЖАЩАЯ ЭЗОМЕПРАЗОЛ ИЛИ ЕГО ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМУЮ СОЛЬ
JP2015500853A (ja) 即時放出マルチユニットペレットシステム
KR20160021095A (ko) 탐술로신 또는 이의 염의 약학 조성물
TWI858268B (zh) 醫藥組成物及其用途
EP3648745B1 (fr) Composition pharmaceutique comprenant un comprimé sphéroïdal à unités multiples contenant de l'ésoméprazole et un sel de qualité pharmaceutique de celui-ci, et procédé de préparation de la composition pharmaceutique
US20190247316A1 (en) Esomeprazole-containing complex capsule and preparation method therefor
RS62113B1 (sr) Farmaceutske kompozicije antagoniste 5-ht6
US20220016058A1 (en) Pharmaceutical composition containing tamsulosin hydrochloride with excellent acid resistance and preparation method therefor
US20120121700A1 (en) Pharmaceutical formulations comprising valganciclovir
JPH11335302A (ja) 安定な医薬組成物
JP7058104B2 (ja) アプレピタントを有効成分とする医薬錠剤
US20210346374A1 (en) Pharmaceutical compositions of 5-ht6 receptor antagonist
CN115666533B (zh) 具有改善的安全性和稳定性的含吡非尼酮的肠溶包衣制剂及其制备方法
BR112019006588B1 (pt) Composição farmacêutica de liberação imediata
NZ752060B2 (en) Pharmaceutical compositions of 5-ht6 antagonist
HK40001843A (en) Pharmaceutical compositions of 5-ht6 antagonist
CA2973944C (fr) Composition solide de pyrrole carboxamide
JP2025075898A (ja) ボスチニブ医薬錠剤の製造方法
BR102021013921A2 (pt) Composição compreendendo o dexlansoprazol
HK40050171A (en) Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonate
BR112021002796B1 (pt) Comprimido e método para preparar um comprimido
HK1247826B (en) Solid composition of pyrrole carboxamide